Deep 6 AI Announces Substantial Expansion of its Innovative AI-Based Clinical Trial Acceleration Software and Research Ecosystem

PASADENA, Calif.--(BUSINESS WIRE)--Deep 6 AI, the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), today announced significant growth.

Click to view original post